# RiconPharma LLC – FDA Inspection, Sep 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/riconpharma-llc/b2fe9bfd-fc81-47dd-900c-5abc6ad3efa5
Source feed: FDA_Inspections

> FDA inspection 1249674 of RiconPharma LLC, September 20, 2024. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1249674
- Company Name: RiconPharma LLC
- Inspection Date: 2024-09-20
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1344452 - 2026-09-24
- FDA Inspection 1157388 - 2021-11-09
- FDA Inspection 1105217 - 2019-09-13
- [FDA Inspection 998568 - 2017-01-09](https://www.keypedia.com/records/fda_inspections/riconpharma-llc/933e7bcc-5afa-4942-b8fc-dfe4298150e3)
- FDA Inspection 910604 - 2015-01-21

## Related Officers

- [Company Rep](https://www.keypedia.com/people/anthony-j-donato/a6dd6e14-529e-4b23-9b5f-02c88afb80ae)
- [Company Rep](https://www.keypedia.com/people/ifechimere-i-okafor/c48399bf-47d9-4562-9130-1e6731eca07d)
- [Investigator](https://www.keypedia.com/people/jenny-sung/f0bfe57e-92b9-4879-9ac3-1e3483b6486a)
- [Investigator](https://www.keypedia.com/people/stephenie-m-ortiz/b0923b14-b153-4893-8eb2-f5e6b1fd2041)

Company: https://www.keypedia.com/companies/riconpharma-llc/419021d0-2e97-46b7-977f-1df932afc40b

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
